Cargando…
Targeting Neuroblastoma Cell Surface Proteins: Recommendations for Homology Modeling of hNET, ALK, and TrkB
Targeted therapy is a promising approach for treatment of neuroblastoma as evident from the large number of targeting agents employed in clinical practice today. In the absence of known crystal structures, researchers rely on homology modeling to construct template-based theoretical structures for d...
Autores principales: | Haddad, Yazan, Heger, Zbyněk, Adam, Vojtech |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247432/ https://www.ncbi.nlm.nih.gov/pubmed/28163672 http://dx.doi.org/10.3389/fnmol.2017.00007 |
Ejemplares similares
-
Trk Receptors and Neurotrophin Cross-Interactions: New Perspectives Toward Manipulating Therapeutic Side-Effects
por: Haddad, Yazan, et al.
Publicado: (2017) -
Ten quick tips for homology modeling of high-resolution protein 3D structures
por: Haddad, Yazan, et al.
Publicado: (2020) -
Homology modeling in the time of collective and artificial intelligence
por: Hameduh, Tareq, et al.
Publicado: (2020) -
Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma
por: Pacenta, Holly L, et al.
Publicado: (2018) -
‘Messy’ Processing of χ-conotoxin MrIA Generates Homologues with Reduced hNET Potency
por: Ziegman, Rebekah, et al.
Publicado: (2019)